{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:19:00Z","timestamp":1777951140105,"version":"3.51.4"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"2","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Integrative medicine, which combines complementary and alternative\nmedicine (CAM) with conventional treatments, is increasingly utilized by patients with systemic\nlupus erythematosus (SLE) to manage their condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to review the CAM available for SLE patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Studies focusing on CAM interventions in patients diagnosed with SLE were identified\nvia PubMed, Scopus, Cochrane Library, and Google Scholar through a systematic search conducted\nto identify relevant articles published up to May 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The potential therapeutic roles of specific micronutrients (vitamins A, C, D, and E),\nmacronutrients (omega-3 fatty acids and probiotics), and supplements (ginger, turmeric) were examined,\ndetailing their mechanisms and emerging evidence supporting their use. Additionally, the\nroles of dietary changes and mind-body interventions were discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Despite the absence of established guidelines for supplementation and other interventions,\nthis review emphasizes the need for personalized approaches tailored to individual characteristics\nand comorbidities. Healthcare providers are encouraged to enhance their knowledge of these\nCAM modalities to optimize patient care and improve overall quality of life for SLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115733971389117250807101431","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T09:45:45Z","timestamp":1755855945000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Rheumatology: A Holistic Approach to the Management of Systemic Lupus Erythematosus"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-697X","authenticated-orcid":true,"given":"Ailia","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Rheumatology, The University of Chicago, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kichul","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Rheumatology, The University of Chicago, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Trotter","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Rheumatology, The University of Chicago, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1","author":"Barnes P.M.","year":"2008","unstructured":"Barnes P.M.; Bloom B.; Nahin R.L.; Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep  2008(12),1-23","journal-title":"Natl Health Stat Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","volume":"27","author":"Schmeding A.","year":"2013","unstructured":"Schmeding A.; Schneider M.; Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol  2013,27(3),363-375","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/acr.23794","volume":"71","author":"Pisetsky D.S.","year":"2019","unstructured":"Pisetsky D.S.; Clowse M.E.B.; Criscione-Schreiber L.G.; Rogers J.L.; A novel system to categorize the symptoms of systemic lupus erythematosus. Arthritis Care Res  2019,71(6),735-741","journal-title":"Arthritis Care Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11926-013-0378-3","volume":"15","author":"Greco C.M.","year":"2013","unstructured":"Greco C.M.; Nakajima C.; Manzi S.; Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus. Curr Rheumatol Rep  2013,15(11),378","journal-title":"Curr Rheumatol Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U","volume":"43","author":"Moore A.D.","year":"2000","unstructured":"Moore A.D.; Petri M.A.; Manzi S.; Isenberg D.A.; Gordon C.; Sen\u00e9cal J.L.; St Pierre Y.; Joseph L.; Penrod J.; Fortin P.R.; Sutcliffe N.; Goulet J.R.; Choquette D.; Grodzicky T.; Esdaile J.M.; Clarke A.E.; The use of alternative medical therapies in patients with systemic lupus erythematosus. Arthritis Rheum  2000,43(6),1410-1418","journal-title":"Arthritis Rheum"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10067-008-1082-y","volume":"28","author":"Alvarez-Nemegyei J.","year":"2009","unstructured":"Alvarez-Nemegyei J.; Bautista-Botello A.; D\u00e1vila-Vel\u00e1zquez J.; Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases. Clin Rheumatol  2009,28(5),547-551","journal-title":"Clin Rheumatol"},{"key":"ref=7","volume":"70","author":"Warner L.B.S.","year":"2018","unstructured":"Warner L.B.S.; Utilization of complementary and integrative medicine among lupus patients: A patient centered analysis of perceived effectiveness and preference. Arthritis Rheumatol  2018,70(9)","journal-title":"Arthritis Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10067-016-3197-x","volume":"35","author":"Handono K.","year":"2016","unstructured":"Handono K.; Firdausi S.N.; Pratama M.Z.; Endharti A.T.; Kalim H.; Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus. Clin Rheumatol  2016,35(3),631-638","journal-title":"Clin Rheumatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00296-014-3067-2","volume":"35","author":"Miyabe Y.","year":"2015","unstructured":"Miyabe Y.; Miyabe C.; Nanki T.; Could retinoids be a potential treatment for rheumatic diseases? Rheumatol Int  2015,35(1),35-41","journal-title":"Rheumatol Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/rheumatology\/ker116","volume":"50","author":"Yang J.","year":"2011","unstructured":"Yang J.; Yang X.; Zou H.; Chu Y.; Li M.; Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology  2011,50(8),1366-1372","journal-title":"Rheumatology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/immunohorizons.2200015","volume":"7","author":"Abdelhamid L.","year":"2023","unstructured":"Abdelhamid L.; Alajoleen R.; Kingsmore K.M.; Cabana-Puig X.; Lu R.; Zhu J.; Testerman J.C.; Li Y.; Ross A.C.; Cecere T.E.; Reilly C.M.; Grammer A.C.; Lipsky P.E.; Luo X.M.; Hypovitaminosis a drives the progression of tubulointerstitial lupus nephritis through potentiating predisease cellular autoreactivity. Immunohorizons  2023,7(1),17-29","journal-title":"Immunohorizons"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.ajkd.2009.06.012","volume":"55","author":"Kinoshita K.","year":"2010","unstructured":"Kinoshita K.; Kishimoto K.; Shimazu H.; Nozaki Y.; Sugiyama M.; Ikoma S.; Funauchi M.; Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis  2010,55(2),344-347","journal-title":"Am J Kidney Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00467-023-06189-1","volume":"39","author":"Santiworakul C.","year":"2024","unstructured":"Santiworakul C.; Saisorn W.; Siripen N.; Leelahavanichkul A.; Rianthavorn P.; Interleukin-8 and neutrophil extracellular traps in children with lupus nephritis and vitamin C deficiency. Pediatr Nephrol  2024,39(4),1135-1142","journal-title":"Pediatr Nephrol"},{"key":"ref=14","first-page":"747","volume":"30","author":"Minami Y.","year":"2003","unstructured":"Minami Y.; Sasaki T.; Arai Y.; Kurisu Y.; Hisamichi S.; Diet and systemic lupus erythematosus: A 4 year prospective study of Japanese patients. J Rheumatol  2003,30(4),747-754","journal-title":"J Rheumatol"},{"key":"ref=15","first-page":"275","volume":"32","author":"Tam L.S.","year":"2005","unstructured":"Tam L.S.; Li E.K.; Leung V.Y.; Griffith J.F.; Benzie I.F.; Lim P.L.; Whitney B.; Lee V.W.; Lee K.K.; Thomas G.N.; Tomlinson B.; Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: A double blind, placebo controlled pilot study. J Rheumatol  2005,32(2),275-282","journal-title":"J Rheumatol"},{"key":"ref=16","first-page":"460","volume":"6","author":"Patavino T.","year":"2001","unstructured":"Patavino T.; Brady D.M.; Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev  2001,6(5),460-471","journal-title":"Altern Med Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3389\/fimmu.2020.01477","volume":"11","author":"Islam M.A.","year":"2020","unstructured":"Islam M.A.; Khandker S.S.; Kotyla P.J.; Hassan R.; Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (sle): A systematic review. Front Immunol  2020,11,1477","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1252594","DOI":"10.3389\/fped.2023.1252594","volume":"11","author":"Jiang L.","year":"2023","unstructured":"Jiang L.; Zhi S.; Wei C.; Rong Z.; Zhang H.; Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus. Front Pediatr  2023,11,1252594","journal-title":"Front Pediatr"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00296-023-05465-5","volume":"44","author":"Zhang X.","year":"2023","unstructured":"Zhang X.; Guo Q.; Sun S.; Tang X.; Shen W.; Liang J.; Yao G.; Geng L.; Ding S.; Chen H.; Wang H.; Hua B.; Wang D.; Zhang H.; Feng X.; Sun L.; Jin Z.; Factors associated with 25-hydroxyvitamin D level in Chinese hospitalized patients with systemic lupus erythematosus: A retrospective cohort study. Rheumatol Int  2023,44(10),2067-2078","journal-title":"Rheumatol Int"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e14092","DOI":"10.1111\/eci.14092","volume":"54","author":"Kim J.W.","year":"2024","unstructured":"Kim J.W.; Baek W.Y.; Jung J.Y.; Kim H.A.; in Yang C.; Kim S.J.; Suh C.H.; Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus. Eur J Clin Invest  2024,54(1),e14092","journal-title":"Eur J Clin Invest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.amjms.2019.04.020","volume":"358","author":"Zheng R.","year":"2019","unstructured":"Zheng R.; Gonzalez A.; Yue J.; Wu X.; Qiu M.; Gui L.; Zhu S.; Huang L.; Efficacy and safety of vitamin d supplementation in patients with systemic lupus erythematosus: a meta-analysis of randomized controlled trials. Am J Med Sci  2019,358(2),104-114","journal-title":"Am J Med Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2174\/0115733971276106231226071002","volume":"20","author":"Wahono C.S.","year":"2024","unstructured":"Wahono C.S.; Susianti H.; Hakim A.L.; Rosita F.; Pratama M.Z.; Rahman P.A.; Anshory M.; Randomised clinical trial study: The combination of vitamin D and curcumin piperine attenuates disease activity and pro-inflammatory cytokines levels insystemic lupus erythematosus patients. Curr Rheumatol Rev  2024,20(5),586-594","journal-title":"Curr Rheumatol Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10067-006-0477-x","volume":"26","author":"Maeshima E.","year":"2007","unstructured":"Maeshima E.; Liang X.M.; Goda M.; Otani H.; Mune M.; The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: A preliminary study. Clin Rheumatol  2007,26(3),401-404","journal-title":"Clin Rheumatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1079\/BJN20051413","volume":"93","author":"Hsieh C.C.","year":"2005","unstructured":"Hsieh C.C.; Lin B.F.; The effects of vitamin E supplementation on autoimmune-prone New Zealand black \u00d7 New Zealand white F1 mice fed an oxidised oil diet. Br J Nutr  2005,93(5),655-662","journal-title":"Br J Nutr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.nut.2004.11.021","volume":"21","author":"Hsieh C.C.","year":"2005","unstructured":"Hsieh C.C.; Lin B.F.; Opposite effects of low and high dose supplementation of vitamin E on survival of MRL\/lpr mice. Nutrition  2005,21(9),940-948","journal-title":"Nutrition"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e001033","DOI":"10.1136\/lupus-2023-001033","volume":"10","author":"Githaiga F.M.","year":"2023","unstructured":"Githaiga F.M.; Omwenga G.I.; Ngugi M.P.; in vivo ameliorative effects of vitamin E against hydralazine-induced lupus. Lupus Sci Med  2023,10(2),e001033","journal-title":"Lupus Sci Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3389\/fimmu.2019.02241","volume":"10","author":"Li X.","year":"2019","unstructured":"Li X.; Bi X.; Wang S.; Zhang Z.; Li F.; Zhao A.Z.; Therapeutic potential of \u03c9-3 polyunsaturated fatty acids in human autoimmune diseases. Front Immunol  2019,10,2241","journal-title":"Front Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/09612033221140724","volume":"32","author":"Salek M.","year":"2023","unstructured":"Salek M.; Hooshiar HS.; Salek M.; Poorebrahimi M.; Jafarnejad S.; Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus. Lupus  2023,32(1),7-22","journal-title":"Lupus"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"849086","DOI":"10.3389\/fmed.2022.849086","volume":"9","author":"Moschetti L.","year":"2022","unstructured":"Moschetti L.; Piantoni S.; Vizzardi E.; Sciatti E.; Riccardi M.; Franceschini F.; Cavazzana I.; Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: A common trigger for different microvascular diseases. Front Med  2022,9,849086","journal-title":"Front Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.rbre.2016.09.014","volume":"57","author":"Curado Borges M.","year":"2017","unstructured":"Curado Borges M.; de Miranda Moura dos Santos F.; Weiss Telles R.; Melo de Andrade M.V.; Correia TDM.I.; Lanna C.C.D.; Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: A pilot study. Rev Bras Reumatol Engl Ed  2017,57(6),526-534","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00296-013-2811-3","volume":"33","author":"Bello K.J.","year":"2013","unstructured":"Bello K.J.; Fang H.; Fazeli P.; Bolad W.; Corretti M.; Magder L.S.; Petri M.; Omega-3 in SLE: A double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol Int  2013,33(11),2789-2796","journal-title":"Rheumatol Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/ard.2007.077156","volume":"67","author":"Wright S.A.","year":"2008","unstructured":"Wright S.A.; O\u2019Prey F.M.; McHenry M.T.; Leahey W.J.; Devine A.B.; Duffy E.M.; Johnston D.G.; Finch M.B.; Bell A.L.; McVeigh G.E.; A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis  2008,67(6),841-848","journal-title":"Ann Rheum Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/RHU.0000000000000563","volume":"23","author":"Akbar U.","year":"2017","unstructured":"Akbar U.; Yang M.; Kurian D.; Mohan C.; Omega-3 fatty acids in rheumatic diseases. J Clin Rheumatol  2017,23(6),330-339","journal-title":"J Clin Rheumatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fimmu.2015.00608","volume":"6","author":"Mu Q.","year":"2015","unstructured":"Mu Q.; Zhang H.; Luo X.M.; SLE: Another autoimmune disorder influenced by microbes and diet? Front Immunol  2015,6,608","journal-title":"Front Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"102459","DOI":"10.1016\/j.autrev.2020.102459","volume":"19","author":"Vojdani A.","year":"2020","unstructured":"Vojdani A.; Gushgari L.R.; Vojdani E.; Interaction between food antigens and the immune system: Association with autoimmune disorders. Autoimmun Rev  2020,19(3),102459","journal-title":"Autoimmun Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41584-023-01071-8","volume":"20","author":"Silverman G.J.","year":"2024","unstructured":"Silverman G.J.; Azzouz D.F.; Gisch N.; Amarnani A.; The gut microbiome in systemic lupus erythematosus: Lessons from rheumatic fever. Nat Rev Rheumatol  2024,20(3),143-157","journal-title":"Nat Rev Rheumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.3390\/ijms23158223","volume":"23","author":"Charoensappakit A.","year":"2022","unstructured":"Charoensappakit A.; Sae-khow K.; Leelahavanichkul A.; Gut barrier damage and gut translocation of pathogen molecules in lupus, an impact of innate immunity (macrophages and neutrophils) in autoimmune disease. Int J Mol Sci  2022,23(15),8223","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1202850","DOI":"10.3389\/fimmu.2023.1202850","volume":"14","author":"Yao K.","year":"2023","unstructured":"Yao K.; Xie Y.; Wang J.; Lin Y.; Chen X.; Zhou T.; Gut microbiota: A newly identified environmental factor in systemic lupus erythematosus. Front Immunol  2023,14,1202850","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3390\/cells11213419","volume":"11","author":"Widhani A.","year":"2022","unstructured":"Widhani A.; Djauzi S.; Suyatna F.D.; Dewi B.E.; Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells  2022,11(21),3419","journal-title":"Cells"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"759095","DOI":"10.3389\/fphar.2021.759095","volume":"12","author":"Guo X.","year":"2021","unstructured":"Guo X.; Yang X.; Li Q.; Shen X.; Zhong H.; Yang Y.; The microbiota in systemic lupus erythematosus: An update on the potential function of probiotics. Front Pharmacol  2021,12,759095","journal-title":"Front Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.jaut.2022.102844","volume":"130","author":"Huang C.","year":"2022","unstructured":"Huang C.; Yi P.; Zhu M.; Zhou W.; Zhang B.; Yi X.; Long H.; Zhang G.; Wu H.; Tsokos G.C.; Zhao M.; Lu Q.; Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An explorer trial. J Autoimmun  2022,130,102844","journal-title":"J Autoimmun"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502","volume":"64","author":"Lai Z.W.","year":"2012","unstructured":"Lai Z.W.; Hanczko R.; Bonilla E.; Caza T.N.; Clair B.; Bartos A.; Miklossy G.; Jimah J.; Doherty E.; Tily H.; Francis L.; Garcia R.; Dawood M.; Yu J.; Ramos I.; Coman I.; Faraone S.V.; Phillips P.E.; Perl A.; N -acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum  2012,64(9),2937-2946","journal-title":"Arthritis Rheum"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/art.37893","volume":"65","author":"Garcia R.J.","year":"2013","unstructured":"Garcia R.J.; Francis L.; Dawood M.; Lai Z.W.; Faraone S.V.; Perl A.; Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum  2013,65(5),1313-1318","journal-title":"Arthritis Rheum"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13063-023-07083-9","volume":"24","author":"Abbasifard M.","year":"2023","unstructured":"Abbasifard M.; Khorramdelazad H.; Rostamian A.; Rezaian M.; Askari P.S.; Sharifi G.T.K.; Parizi M.K.; Sharifi M.T.K.; Najafizadeh S.R.; Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: A randomized double-blind clinical trial study. Trials  2023,24(1),129","journal-title":"Trials"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2710.2009.01108.x","volume":"35","author":"Tewthanom K.","year":"2009","unstructured":"Tewthanom K.; Janwitayanujit S.; Totemchockcyakarn K.; Panomvana Na Ayudhya D.; The effect of high dose of N -acetylcysteine in lupus nephritis: A case report and literature review. J Clin Pharm Ther  2009,35(4),483-485","journal-title":"J Clin Pharm Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3892\/etm.2015.2510","volume":"10","author":"Li M.","year":"2015","unstructured":"Li M.; Gao W.; Ma J.; Zhu Y.; Li X.; Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases. Exp Ther Med  2015,10(2),689-692","journal-title":"Exp Ther Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e00010","DOI":"10.1097\/IN9.0000000000000010","volume":"4","author":"Nasr S.","year":"2022","unstructured":"Nasr S.; Perl A.; Principles behind SLE treatment with N-acetylcysteine. Immunometabolism  2022,4(4),e00010","journal-title":"Immunometabolism"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.3390\/molecules27217223","volume":"27","author":"Ballester P.","year":"2022","unstructured":"Ballester P.; Cerd\u00e1 B.; Arcusa R.; Marhuenda J.; Yamedjeu K.; Zafrilla P.; Effect of ginger on inflammatory diseases. Molecules  2022,27(21),7223","journal-title":"Molecules"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e138385","DOI":"10.1172\/jci.insight.138385","volume":"6","author":"Ali R.A.","year":"2021","unstructured":"Ali R.A.; Gandhi A.A.; Dai L.; Weiner J.; Estes S.K.; Yalavarthi S.; Gockman K.; Sun D.; Knight J.S.; Antineutrophil properties of natural gingerols in models of lupus. JCI Insight  2021,6(3),e138385","journal-title":"JCI Insight"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e172011","DOI":"10.1172\/jci.insight.172011","volume":"8","author":"Ali R.A.","year":"2023","unstructured":"Ali R.A.; Minarchick V.C.; Zahavi M.; Rysenga C.E.; Sturm K.A.; Hoy C.K.; Sarosh C.; Knight J.S.; Demoruelle M.K.; Ginger intake suppresses neutrophil extracellular trap formation in autoimmune mice and healthy humans. JCI Insight  2023,8(18),e172011","journal-title":"JCI Insight"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/ptr.7417","volume":"36","author":"Chamani S.","year":"2022","unstructured":"Chamani S.; Moossavi M.; Naghizadeh A.; Abbasifard M.; Majeed M.; Johnston T.P.; Sahebkar A.; Immunomodulatory effects of curcumin in systemic autoimmune diseases. Phytother Res  2022,36(4),1616-1632","journal-title":"Phytother Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/09612033231161961","volume":"32","author":"Ramessar N.","year":"2023","unstructured":"Ramessar N.; Borad A.; Schlesinger N.; The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review. Lupus  2023,32(5),644-657","journal-title":"Lupus"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.intimp.2019.01.046","volume":"69","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Wang J.; Zhou M.; Li M.; Li M.; Tan H.; Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome. Int Immunopharmacol  2019,69,213-216","journal-title":"Int Immunopharmacol"},{"key":"ref=54","first-page":"2075","volume":"12","author":"Li Q.","year":"2019","unstructured":"Li Q.; Tan S.; Xu K.; Fu X.; Yu J.; Yang H.; Wang H.; Curcumin attenuates lupus nephritis in MRL\/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF). Int J Clin Exp Pathol  2019,12(6),2075-2083","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"Momtazi-Borojeni A.A.","year":"2018","unstructured":"Momtazi-Borojeni A.A.; Haftcheshmeh S.M.; Esmaeili S.A.; Johnston T.P.; Abdollahi E.; Sahebkar A.; Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev  2018,17(2),125-135","journal-title":"Autoimmun Rev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.jrn.2011.03.002","volume":"22","author":"Khajehdehi P.","year":"2012","unstructured":"Khajehdehi P.; Zanjaninejad B.; Aflaki E.; Nazarinia M.; Azad F.; Malekmakan L.; Dehghanzadeh G.R.; Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: A randomized and placebo-controlled study. J Ren Nutr  2012,22(1),50-57","journal-title":"J Ren Nutr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7687053","volume":"2017","author":"Wahono C.S.","year":"2017","unstructured":"Wahono C.S.; Setyorini C.D.; Kalim H.; Nurdiana N.; Handono K.; Effect of Curcuma xanthorrhiza supplementation on systemic lupus erythematosus patients with hypovitamin D which were given vitamin D  towards disease activity (SLEDAI), IL-6, and TGF- \u03b2 1 Serum. Int J Rheumatol  2017,2017,1-8","journal-title":"Int J Rheumatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14499\/indonesianjpharm28iss3pp185","volume":"28","author":"Setiawati M.C.","year":"2017","unstructured":"Setiawati M.C.; Ikawati Z.; Kertia I.N.; Antiinflamatory and antidepressive activities of extract curcuma xanthorrhiza roxb in systemic lupus erythematosus. Indones J Pharm  2017,28(3),185","journal-title":"Indones J Pharm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/etm.2018.6986","volume":"17","author":"Constantin M.M.","year":"2018","unstructured":"Constantin M.M.; Nita I.; Olteanu R.; Constantin T.; Bucur S.; Matei C.; Raducan A.; Significance and impact of dietary factors on systemic lupus erythematosus pathogenesis (Review). Exp Ther Med  2018,17(2),1085-1090","journal-title":"Exp Ther Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/09612033211063795","volume":"31","author":"Knippenberg A.","year":"2022","unstructured":"Knippenberg A.; Robinson G.A.; Wincup C.; Ciurtin C.; Jury E.C.; Kalea A.Z.; Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus. Lupus  2022,31(1),65-76","journal-title":"Lupus"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1208074","DOI":"10.3389\/fnut.2024.1208074","volume":"11","author":"Goldner B.","year":"2024","unstructured":"Goldner B.; Staffier K.L.; Case series: Raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. Front Nutr  2024,11,1208074","journal-title":"Front Nutr"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/rheumatology\/keaa210","volume":"60","author":"Pocovi-Gerardino G.","year":"2021","unstructured":"Pocovi-Gerardino G.; Correa-Rodr\u00edguez M.; Callejas-Rubio J.L.; R\u00edos-Fern\u00e1ndez R.; Mart\u00edn-Amada M.; Cruz-Caparros M.G.; Rueda-Medina B.; Ortego-Centeno N.; Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: A cross-sectional study. Rheumatology  2021,60(1),160-169","journal-title":"Rheumatology"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e000898","DOI":"10.1136\/lupus-2023-000898","volume":"10","author":"Zhang X.","year":"2023","unstructured":"Zhang X.; Meng J.; Shi X.; Quinet R.J.; Davis W.; Zakem J.; Keshavamurthy C.; Patel R.; Lobo G.; Hellmers L.; Ray A.N.; Rivers L.E.; Ali H.; Posas-Mendoza T.; Hille C.; You Z.; Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL\/lpr mice. Lupus Sci Med  2023,10(1),e000898","journal-title":"Lupus Sci Med"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014816","volume":"2021","author":"Frade S.","year":"2021","unstructured":"Frade S.; O\u2019Neill S.; Greene D.; Cameron M.; Exercise as adjunctive therapy for systemic lupus erythematosus. Cochrane Libr  2021,2021(10)","journal-title":"Cochrane Libr"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ctim.2018.09.001","volume":"41","author":"Middleton K.R.","year":"2018","unstructured":"Middleton K.R.; Moonaz HS.; Hasni S.A.; Maga\u00f1a L\u00f3pez M.; Tataw-Ayuketah G.; Farmer N.; Wallen G.R.; Yoga for systemic lupus erythematosus (SLE): Clinician experiences and qualitative perspectives from students and yoga instructors living with SLE. Complement Ther Med  2018,41,111-117","journal-title":"Complement Ther Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3899\/jrheum.141129","volume":"42","author":"Moonaz S.H.","year":"2015","unstructured":"Moonaz S.H.; Bingham C.O.; Wissow L.; Bartlett S.J.; Yoga in sedentary adults with arthritis: Effects of a randomized controlled pragmatic trial. J Rheumatol  2015,42(7),1194-1202","journal-title":"J Rheumatol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/rheumatology\/kem151","volume":"46","author":"Lee M.S.","year":"2007","unstructured":"Lee M.S.; Pittler M.H.; Ernst E.; Tai chi for rheumatoid arthritis: Systematic review. Rheumatology  2007,46(11),1648-1651","journal-title":"Rheumatology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"CD004849","DOI":"10.1002\/14651858.CD004849","author":"Han A.","year":"2004","unstructured":"Han A.; Judd M.; Welch V.; Wu T.; Tugwell P.; Wells G.A.; Tai chi for treating rheumatoid arthritis. Cochrane Libr  2004(3),CD004849","journal-title":"Cochrane Libr"},{"key":"ref=69","volume":"69","author":"Yedimenko J TE","year":"2017","unstructured":"Yedimenko J TE; Snoad B; Sharma J; Mobeen M; Steigelman H; Meara A; Valiente GR; Ardoin SP; Powell N; Sheridan J; Jarjour W; Young NA; The effects of Tai Chi on inflammatory mediator secretion in systemic lupus erythematosus. Arthritis Rheumatol  2017,69(10)","journal-title":"Arthritis Rheumatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.semarthrit.2017.04.003","volume":"47","author":"O\u2019Dwyer T.","year":"2017","unstructured":"O\u2019Dwyer T.; Durcan L.; Wilson F.; Exercise and physical activity in systemic lupus erythematosus: A systematic review with meta-analyses. Semin Arthritis Rheum  2017,47(2),204-215","journal-title":"Semin Arthritis Rheum"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/ard-2023-224416","volume":"83","author":"Parodis I.","year":"2024","unstructured":"Parodis I.; Girard-Guyonvarc\u2019h C.; Arnaud L.; Distler O.; Domj\u00e1n A.; Van den Ende C.H.M.; Fligelstone K.; Kocher A.; Larosa M.; Lau M.; Mitropoulos A.; Ndosi M.; Poole J.L.; Redmond A.; Ritschl V.; Alexanderson H.; Sj\u00f6berg Y.; von Perner G.; Uhlig T.; Varju C.; Vriezekolk J.E.; Welin E.; Westhovens R.; Stamm T.A.; Bostr\u00f6m C.; Eular recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis  2024,83(6),720-729","journal-title":"Ann Rheum Dis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e35418","DOI":"10.1097\/MD.0000000000035418","volume":"102","author":"Wang H.","year":"2023","unstructured":"Wang H.; Wang B.; Huang J.; Yang Z.; Song Z.; Zhu Q.; Xie Z.; Sun Q.; Zhao T.; Efficacy and safety of acupuncture therapy combined with conventional pharmacotherapy in the treatment of systemic lupus erythematosus: A systematic review and meta-analysis. Medicine  2023,102(40),e35418","journal-title":"Medicine"},{"key":"ref=73","first-page":"1","author":"Nahin R.L.","year":"2016","unstructured":"Nahin R.L.; Barnes P.M.; Stussman B.J.; Insurance coverage for complementary health approaches among adult users: United States, 2002 and 2012. NCHS Data Brief  2016(235),1-8","journal-title":"NCHS Data Brief"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4297\/najms.2011.320","volume":"3","author":"Niazi A.","year":"2011","unstructured":"Niazi A.; Niazi S.; Mindfulness-based stress reduction: A non-pharmacological approach for chronic illnesses. N Am J Med Sci  2011,3(1),20-23","journal-title":"N Am J Med Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.3390\/jcm10194450","volume":"10","author":"Taub R.","year":"2021","unstructured":"Taub R.; Horesh D.; Rubin N.; Glick I.; Reem O.; Shriqui G.; Agmon-Levin N.; Mindfulness-based stress reduction for systemic lupus erythematosus: A mixed-methods pilot randomized controlled trial of an adapted protocol. J Clin Med  2021,10(19),4450","journal-title":"J Clin Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ctcp.2016.11.011","volume":"26","author":"Horesh D.","year":"2017","unstructured":"Horesh D.; Glick I.; Taub R.; Agmon-Levin N.; Shoenfeld Y.; Mindfulness-based group therapy for systemic lupus erythematosus: A first exploration of a promising mind-body intervention. Complement Ther Clin Pract  2017,26,73-75","journal-title":"Complement Ther Clin Pract"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971389117250807101431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244584\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971389117250807101431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:07:48Z","timestamp":1777885668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244584\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733971389117250807101431","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}